卒中试验中失语症患者的纳入情况:系统检索与综述
该系统综述检索2019年发表的卒中随机对照试验(RCT)及方案,评估失语症患者(PwA)的纳入情况。271项研究中仅6.5%的已完成RCT明确纳入PwA,88.8%纳入情况不明,且71.2%未报告任何支持性调整。
要点
- 仅6.5%的已完成RCT明确纳入失语症患者,88.8%纳入情况不明。
- 45.8%的研究通过明确或模糊标准排除了失语症亚组。
- 71.2%的已完成RCT未报告任何支持失语症患者参与的调整。
核心结论
- 失语症患者在当代卒中RCT中纳入情况普遍不明确或不足,限制了研究外推性并引发伦理问题。
研究设计与样本
- 系统检索2019年发表的已完成卒中RCT和RCT方案,共纳入271项研究(215项已完成RCT,56项方案)。
主要发现
- 36.2%的研究提及失语症/言语障碍;已完成RCT中仅6.5%明确纳入PwA,4.7%明确排除,88.8%纳入情况不明。
- RCT方案中28.6%计划纳入PwA,10.7%计划排除,60.7%纳入情况不明。
- 45.8%的研究通过明确或模糊标准排除了失语症亚组,且很少提供排除理由。
- 71.2%的已完成RCT未报告任何支持PwA纳入的调整,同意程序信息极少。
- 可确定时,PwA的脱落率平均为10%(范围0%-20%)。
关键数值与推荐
- 已完成RCT明确纳入PwA的比例为6.5%,明确排除为4.7%,纳入不明为88.8%。
- RCT方案计划纳入PwA的比例为28.6%,计划排除为10.7%,纳入不明为60.7%。
- 45.8%的研究排除了PwA亚组;71.2%的已完成RCT未报告支持性调整。
- PwA脱落率平均10%(范围0%-20%)。
临床怎么用
- 卒中康复研究应明确说明是否纳入失语症患者,并报告支持其参与的调整措施。
- 设计试验时应避免使用模糊排除标准,减少对失语症亚组的无意排除。
局限性
- 仅检索2019年发表的文献,可能不能代表全部卒中RCT。
- 纳入情况不明的研究较多,影响对实际纳入比例的准确判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although people with aphasia (PwA) represent 30% of stroke survivors, they are frequently excluded from stroke research, or their inclusion is unclear. Such practice significantly limits the generalizability of stroke research, increases the need to duplicate research in aphasia-specific populations, and raises important ethical and human rights issues. OBJECTIVE: To detail the extent and nature of inclusion of PwA in contemporary stroke randomized controlled trials (RCTs). METHODS: We conducted a systematic search to identify completed stroke RCTs and RCT protocols published in 2019. Web of Science was searched using terms "stroke" and "randomized controlled trial". These articles were reviewed by extracting rates of PwA inclusion/exclusion, whether "aphasia" or related terms were referred to in the article or supplemental files, eligibility criteria, consent procedures, adaptations made to support the inclusion of PwA, and attrition rates of PwA. Data were summarized, and descriptive statistics applied when appropriate. RESULTS: 271 studies comprising 215 completed RCTs and 56 protocols were included. 36.2% of included studies referred to aphasia/dysphasia. Of completed RCTs, only 6.5% explicitly included PwA, 4.7% explicitly excluded PwA, and inclusion was unclear in the remaining 88.8%. Among RCT protocols, 28.6% of studies intended inclusion, 10.7% intended excluding PwA, and in 60.7%, inclusion was unclear. In 45.8% of included studies, sub-groups of PwA were excluded, either explicitly (ie, particular types/severities of aphasia, eg, global aphasia) or implicitly, by way of ambiguous eligibility criteria which could potentially relate to a sub-group of PwA. Little rationale for exclusion was provided. 71.2% of completed RCTs did not report any adaptations that could support the inclusion of PwA, and minimal information was provided about consent procedures. Where it could be determined, attrition of PwA averaged 10% (range 0%-20%). CONCLUSION: This paper details the extent of inclusion of PwA in stroke research and highlights opportunities for improvement.
引用
- Shiggins C, Ryan B, Dewan F, et al. Inclusion of People With Aphasia in Stroke Trials: A Systematic Search and Review. Arch Phys Med Rehabil. 2023. PMID: 37394026. doi:10.1016/j.apmr.2023.06.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。